Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults

ClinicalTrials.gov ID: NCT05014568

Public ClinicalTrials.gov record NCT05014568. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 7:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Moderate to Severe Atopic Dermatitis in Children and Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a double-blind, randomized, vehicle controlled Phase 3 study to evaluate the efficacy and safety of topical tapinarof cream, 1% compared to vehicle control cream in pediatric and adult subjects with atopic dermatitis.

Study identification

NCT ID
NCT05014568
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Organon and Co
Industry
Enrollment
407 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
2 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2021
Primary completion
Mar 29, 2023
Completion
Apr 6, 2023
Last update posted
Sep 3, 2025

2021 – 2023

United States locations

U.S. sites
60
U.S. states
24
U.S. cities
56
Facility City State ZIP Site status
Dermavant Investigative Site Birmingham Alabama 35244
Dermavant Investigative Site Phoenix Arizona 85032
Dermavant Investigative Site Bryant Arkansas 72022
Dermavant Investigative Site Beverly Hills California 90212
Dermavant Investigative Site Fountain Valley California 92708
Dermavant Investigative Site Fremont California 94538
Dermavant Investigative Site Inglewood California 90301
Dermavant Investigative Site Los Angeles California 90017
Dermavant Investigative Site Los Angeles California 90033
Dermavant Investigative Site Mission Viejo California 92691
Dermavant Investigative Site Sacramento California 95815
Dermavant Investigative Site Washington D.C. District of Columbia 20037
Dermavant Investigative Site Boca Raton Florida 33431
Dermavant Investigative Site Boca Raton Florida 33486
Dermavant Investigative Site Brandon Florida 33511
Dermavant Investigative Site Coral Gables Florida 33146
Dermavant Investigative Site Jacksonville Florida 32256
Dermavant Investigative Site Margate Florida 33063
Dermavant Investigative Site Miami Florida 33126
Dermavant Investigative Site Miami Lakes Florida 33014
Dermavant Investigative Site Orlando Florida 32801
Dermavant Investigative Site Pinellas Park Florida 33781
Dermavant Investigative Site Sweetwater Florida 33172
Dermavant Investigative Site Tampa Florida 33615
Dermavant Investigative Site Marietta Georgia 30060
Dermavant Investigative Site Sandy Springs Georgia 30328
Dermavant Investigative Site Savannah Georgia 31406
Dermavant Investigative Site Plainfield Indiana 46168
Dermavant Investigative Site Louisville Kentucky 40217
Dermavant Investigative Site Owensboro Kentucky 42301
Dermavant Investigative Site Covington Louisiana 70433
Dermavant Investigative Site Monroe Louisiana 71201
Dermavant Investigative Site Largo Maryland 20774
Dermavant Investigative Site Bay City Michigan 48706
Dermavant Investigative Site Clarkston Michigan 48346
Dermavant Investigative Site Warren Michigan 48088
Dermavant Investigative Site Ypsilanti Michigan 48197
Dermavant Investigative Site New Brighton Minnesota 55112
Dermavant Investigative Site Missoula Montana 59808
Dermavant Investigative Site Omaha Nebraska 68144
Dermavant Investigative Site Garden City New York 11530
Dermavant Investigative Site New York New York 10075
Dermavant Investigative Site Bexley Ohio 43209
Dermavant Investigative Site Cleveland Ohio 44106
Dermavant Investigative Site Oklahoma City Oklahoma 73071
Dermavant Investigative Site Oklahoma City Oklahoma 73120
Dermavant Investigative Site Gresham Oregon 97030
Dermavant Investigative Site Portland Oregon 97223
Dermavant Investigative Site Hershey Pennsylvania 17033
Dermavant Investigative Site Greenville South Carolina 29615
Dermavant Investigative Site Knoxville Tennessee 37909
Dermavant Investigative Site Austin Texas 78745
Dermavant Investigative Site Bellaire Texas 77401
Dermavant Investigative Site Cypress Texas 77433
Dermavant Investigative Site Dallas Texas 75230
Dermavant Investigative Site Houston Texas 77098
Dermavant Investigative Site San Antonio Texas 78218
Dermavant Investigative Site San Antonio Texas 78229
Dermavant Investigative Site Sugar Land Texas 77479
Dermavant Investigative Site Richmond Virginia 23226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05014568, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 3, 2025 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05014568 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →